Le Lézard
Classified in: Health
Subjects: CCA, BFA, PET, FVT

Aratana Therapeutics to Report Third Quarter 2017 Financial Results

LEAWOOD, Kan., Oct. 5, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, will host a live conference call on Friday, November 3, 2017 at 8:30 a.m. ET to discuss financial results from the third quarter ended September 30, 2017.

Aratana Therapeutics logo

Interested participants and investors may access the audio webcast or use the conference call dial-in:

     1 (866) 364-3820 (U.S.) 
     1 (855) 669-9657 (Canada)
     1 (412) 902-4210 (International)

A replay of the third quarter results teleconference will be available the same day of the event by approximately 11 a.m. ET and an audio webcast will be accessible for 90 days in the Aratana Investor Room. For a replay of the call, use the below dial-in and conference ID 10112622:

     1 (877) 344-7529 (U.S.) 
     1 (855) 669-9658 (Canada
     1 (412) 317-0088 (International)

About Aratana Therapeutics
Aratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to dogs and cats in a capital and time efficient manner. The company's pipeline includes therapeutic candidates for the potential treatment of pain, inappetence, viral diseases, allergy, cancer and other serious medical conditions. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit www.aratana.com.

For investor inquires:
Craig Tooman
(913) 353-1026

For media inquiries:
Rachel Reiff
(913) 353-1050

SOURCE Aratana Therapeutics, Inc.

These press releases may also interest you

at 09:01
U.S. healthcare providers are increasingly leveraging a centrally managed (i.e., enterprise) approach to telemedicine, according to the results of the REACH Health 2018 U.S. Telemedicine Industry Benchmark Survey. Forty-eight percent of respondents...

at 09:00
The BioBricks Foundation (BBF), a public benefit charity promoting biotechnology in the public interest, and Sagacious Research (Sagacious), a private company committed to solving intellectual property and business challenges in the innovation...

at 09:00
According to a recent report published by Forbes, Brightfield Group projects that the global cannabis market was worth $7.7 billion in the end of 2017, and is expected to reach $31.4 billion by 2021. The United States accounts for about 90 percent of...

at 09:00
No one wants to switch utilization management systems. That was especially true for Greensboro-based Triad HealthCare Network (THN). The accountable care organization (ACO) uses a sophisticated utilization management system to approve tests, hospital...

at 09:00
Fresenius Medical Care North America (FMCNA), the country's leading provider of kidney care products and services, announces the appointment of Angela McClure to the newly created role of chief experience officer (CXO). In her new role, McClure will...

at 09:00
Next Insurance, the leading insurtech company offering small business insurance, today launched Live Certificate, a real-time certificate of insurance (COI) verification feature for policyholders and their customers. Next Insurance is the first...

News published on 5 october 2017 at 16:30 and distributed by: